{"id":124296,"date":"2026-09-02T10:39:15","date_gmt":"2026-09-02T10:39:15","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/124296\/"},"modified":"2026-09-02T10:39:15","modified_gmt":"2026-09-02T10:39:15","slug":"novartis-pauses-8-cell-therapy-trials-after-three-die-due-to-severe-immune-reaction","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/124296\/","title":{"rendered":"Novartis pauses 8 cell therapy trials after three die due to severe immune reaction"},"content":{"rendered":"<p>Following the death of three patients who were part of an experimental cell therapy called rap-cel, Novartis decided to pause eight clinical trials. Rap-cel is a type of CAR T-cell therapy in which a patient&#8217;s immune cells are removed, modified to recognise and destroy specific target cells, and reinfused. <\/p>\n<p>The trials were focused on targeting autoimmune and neurological disorders and had to be halted following the deaths in August due to a severe, life-threatening immune reaction. <\/p>\n<p>According to the Swiss drugmaker, complications from the reaction, in which the body&#8217;s defense system overreacts and attacks its own organs, led to the deaths. <\/p>\n<p>U.S. drugmaker Bristol Myers also said it has implemented a voluntary pause on studies for a rival CAR T-cell treatment, zola-cel, &#8220;out of an abundance of caution&#8221; as it reviews safety data, Reuters reported. <\/p>\n<p>Officials at Novartis also said that they were conducting a comprehensive review of the deaths and are also looking into what happened, as well as to find ways to catch dangerous side effects earlier. <\/p>\n<p>As per Reuters, Novartis said that it is actively sharing information with health authorities and will continue to monitor patients who have already received the treatment.<\/p>\n<p>The halted trials include those for inflammatory diseases such as lupus, rheumatoid arthritis, and vasculitis and nerve- and muscle-weakening disorders including multiple sclerosis and myasthenia gravis. <\/p>\n","protected":false},"excerpt":{"rendered":"Following the death of three patients who were part of an experimental cell therapy called rap-cel, Novartis decided&hellip;\n","protected":false},"author":2,"featured_media":124297,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[5681,60738,36657,60804,1288,60805,60801,16181,153,44168,15075,206,30319,40972,60802,60803,60739],"class_list":["post-124296","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-autoimmune-disorders","tag-bristol-myers","tag-car-t-cell-therapy","tag-cell-therapy-pause","tag-clinical-trials","tag-experimental-treatment-safety","tag-immune-reaction","tag-lupus","tag-multiple-sclerosis","tag-myasthenia-gravis","tag-neurological-disorders","tag-novartis","tag-patient-deaths","tag-rap-cel","tag-rheumatoid-arthritis","tag-vasculitis","tag-zola-cel"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117201021643954004","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/124296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=124296"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/124296\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/124297"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=124296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=124296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=124296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}